The largest drug
discovery company
in the CEE region


Your integrated drug
discovery partner of choice


Developing breakthrough
therapies in oncology


Delivering comprehensive
research solutions to biotech
and pharma


News See all

Selvita and Sandoz chemists’ research published in Heterocycles

Krakow, Poland – 20 August 2019 – Selvita and Sandoz researchers have recently jointly published an article: Mini-Review: The Chemistry...

Selvita Appoints Setareh Shamsili, M.D., Ph.D., as Chief Medical…

Krakow, Poland – 25 July 2019 – Selvita, S.A. (WSE: SLV), a leading clinical stage drug discovery company committed to...

Selvita to exhibit at the 20th Annual Drug Discovery…

Krakow, Poland – 5 June 2019 – Selvita, drug discovery and development partner for the pharmaceutical and biotechnology industries, will...

Selvita present at the EFMC-ACSMEDI MedChem Frontiers 2019 Conference

Krakow, Poland – 3 June 2019 – Selvita, a clinical stage drug discovery and development company focused on innovative medicines...

Selvita at the Annual BIO International Convention 2019

Krakow, Poland – 28 May 2019 – Selvita (WSE: SLV), a clinical stage drug discovery and development company focused on...

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.


Drug Discovery Services

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.


Research and Development

In its internal research and development efforts, Selvita focuses on different dimensions of oncology.

The company’s most advanced R&D program is SEL24, a dual PIM/FLT3 kinase inhibitor currently in Phase I/II clinical study, in acute myeloid leukemia.


Investor Relations SLV 0,2000 PLN ( 0,34% )

Share price 2019-08-23 17:00:00

58,6000 PLN More


We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.